25 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
using our platform to discover oral replication inhibitors for the treatment of COVID-19.
“Regarding our influenza programs, our supplier … Human Research Ethics Committees (HREC) to initiate a Phase 1 clinical trial. Our supplier is manufacturing drug and we expect to begin patient
8-K
EX-1.1
hwgoy2n 975ko12j
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
EX-1.1
os3dlkx40r2xexxr i6
2 May 18
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-2.1
gro9sn0w6cmd6r
1 Dec 14
Entry into a Material Definitive Agreement
12:00am